ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
ReShape Lifesciences Revenue
ReShape Lifesciences reported an annual revenue of $8.01M, reflecting a -7.74% growth. For the quarter ending March 31, 2025, ReShape Lifesciences generated $1.11M in revenue.
Revenue (ttm)
8.01M
Revenue Growth
-7.74%
Price / Sales Ratio
7.18
Revenue / Employee
470.94K
Employees
17
Market Cap
9.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 8.01M | -7.74% |
| Dec 31, 2023 | 8.68M | -22.79% |
| Dec 31, 2022 | 11.24M | -17.35% |
| Dec 31, 2021 | 13.6M | +20.36% |
| Dec 31, 2020 | 11.3M | -25.12% |
| Dec 31, 2019 | 15.09M | +2387.02% |
| Dec 31, 2018 | 606.71K | -52.86% |
| Dec 31, 2017 | 1.29M | +63.62% |
| Dec 31, 2016 | 786.66K | +169.40% |
| Dec 31, 2015 | 292K | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | -100.00% |
| Dec 31, 2012 | 312K | +Infinity% |
| Dec 31, 2011 | 0 | n/a |
| Dec 31, 2010 | 0 | n/a |
| Dec 31, 2009 | 0 | n/a |
| Dec 31, 2008 | 0 | n/a |
| Dec 31, 2007 | 0 | n/a |
| Dec 31, 2006 | 0 | n/a |
| Dec 31, 2005 | 0 | n/a |
| Dec 31, 2004 | 0 | n/a |
| Dec 31, 2003 | 0 | n/a |